Efficacy of Therapy with 311nm Narrow-Band UVB in the Treatment of Patients with Alopecia Areata Associated with Atopic Dermatitis

The study evaluated the efficacy of narrowband UVB 311 nm (NB-UVB 311 nm) therapy in treating pediatric patients with alopecia areata (AA) and atopic dermatitis (AD). Involving 49 children aged 5-12, the study compared two groups: 22 patients with both AA and AD, and 27 with only AA. All received standard AA treatment, but the first group also received NB-UVB 311 nm for AD. After 3 months, 77% of the first group showed significant hair regrowth compared to 48% in the second group. The study concluded that NB-UVB 311 nm therapy, when combined with standard treatment, enhances hair regrowth in patients with AA and AD.